Shionogi Inc.
Shionogi Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-04-02 | NCT06161688 | |
| Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, burn, gram-negative bacterial infections, injury | Recruiting | Phase 4 | 2026-03-12 | NCT07465432 |